MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 6 filers reported holding MAINZ BIOMED B V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286 | -93.6% | 98 | -89.5% | 0.00% | – |
| Q2 2023 | $4,450 | -67.8% | 931 | -57.8% | 0.00% | – |
| Q1 2023 | $13,841 | -12.2% | 2,204 | -0.7% | 0.00% | – |
| Q4 2022 | $15,762 | +21.2% | 2,220 | +62.8% | 0.00% | – |
| Q2 2022 | $13,000 | -38.1% | 1,364 | -5.6% | 0.00% | – |
| Q1 2022 | $21,000 | -76.7% | 1,445 | -83.4% | 0.00% | – |
| Q4 2021 | $90,000 | – | 8,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 14,159 | $67,000 | 0.05% |
| UBS Group AG | 931 | $4,450 | 0.00% |
| NewEdge Advisors, LLC | 1,000 | $4,780 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $478 | 0.00% |
| WELLS FARGO & COMPANY/MN | 500 | $2,390 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 673 | $3,217 | 0.00% |
| MORGAN STANLEY | 200 | $956 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,500 | $7,170 | 0.00% |
| JPMORGAN CHASE & CO | 14 | $67 | 0.00% |